Silo Pharma (SILO) Cost of Revenue (2019 - 2025)
Historic Cost of Revenue for Silo Pharma (SILO) over the last 7 years, with Q3 2025 value amounting to $20687.0.
- Silo Pharma's Cost of Revenue rose 131788.9% to $20687.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $25066.0, marking a year-over-year increase of 32935.94%. This contributed to the annual value of $5838.0 for FY2024, which is 0.0% changed from last year.
- As of Q3 2025, Silo Pharma's Cost of Revenue stood at $20687.0, which was up 131788.9% from $1459.0 recorded in Q2 2025.
- Silo Pharma's Cost of Revenue's 5-year high stood at $20687.0 during Q3 2025, with a 5-year trough of $625.0 in Q1 2021.
- Moreover, its 5-year median value for Cost of Revenue was $1460.0 (2021), whereas its average is $2427.6.
- In the last 5 years, Silo Pharma's Cost of Revenue plummeted by 9899.49% in 2021 and then soared by 131788.9% in 2025.
- Silo Pharma's Cost of Revenue (Quarter) stood at $1460.0 in 2021, then changed by 0.0% to $1460.0 in 2022, then changed by 0.0% to $1460.0 in 2023, then changed by 0.0% to $1460.0 in 2024, then soared by 1316.92% to $20687.0 in 2025.
- Its Cost of Revenue was $20687.0 in Q3 2025, compared to $1459.0 in Q2 2025 and $1460.0 in Q1 2025.